MONOPAR THERAPEUTICS Equity (MNPR) insider trading activity (SEC Form 4). Over the trailing 90 days, MNPR insiders filed 0 purchases totalling $0 and 5 sales totalling $4.0M — net SELLING of $4.0M. Most recent filing: Oct 5, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Starr Christopher M | Dir | S SaleOE | — | $78.50 | $659K | filing |
| Sep 28, 2026 | Robinson Chandler | CEO | S SaleOE | — | $88.00 | $2.6M | filing |
| Aug 27, 2026 | Rioux Patrice | Acting Chief Medical Officer | S SaleOE | — | $111.26 | $111 | filing |
| Aug 27, 2026 | Tsuchimoto Kim R | Dir | S Sale | — | $111.39 | $456K | filing |
| Aug 27, 2026 | Anderson Raymond | Dir | S Sale | — | $111.77 | $351K | filing |